// App-Quantinova.ai

11047 : Sequential monitoring of androgen receptor expression and copy number variation in castration-resistant prostate cancer (CRPC).

Researchers

Presenter

  • Mitchell E. Gross

Principal Investigators

  • David B. Agus

  • Tanya B. Dorff

  • James B Hicks

  • Peter Kuhn

  • Jacek K. Pinski

  • David I. Quinn

  • Angel E Dago

  • Asya Stepansky

  • Anders Carlsson

  • Natalie Felch

  • Madelyn Luttgen

  • Anand Kolatkar

Medical Centers

  • University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

  • University of Southern California, Los Angeles, CA

  • University of Southern California Keck School of Medicine, Los Angeles, CA

  • Skyline Genomics, New York, NY

  • Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

  • Scripps Research Institute, La Jolla, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved